Bulletin
Investor Alert

Haemonetics Corp.

NYS: HAE

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

May 26, 2023, 4:01 p.m.

HAE
/zigman2/quotes/205816408/composite

$

83.21

Change

0.00 0.00%

Volume

Volume 5,295

Quotes are delayed by 20 min

/zigman2/quotes/205816408/composite

Previous close

$ 82.88

$ 83.21

Change

+0.33 +0.40%

Day low

Day high

$82.98

$84.00

Open

52 week low

52 week high

$58.23

$91.39

Open

Insider Actions for Haemonetics Corp.

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/02/2023 James C. Darecca
EVP, Chief Financial Officer
430   Derivative/Non-derivative trans. at $81.66 per share. 35,113
04/14/2023 Anila Lingamneni
EVP, Chief Technology Officer
176   Derivative/Non-derivative trans. at $84.78 per share. 14,921
01/23/2023 Josep Lluis Llorens
EVP, Global Manufacturing
2,391   Disposition at $90 per share. 215,190
01/23/2023 Josep Lluis Llorens
EVP, Global Manufacturing
2,391   Derivative/Non-derivative trans. at $56.57 per share. 135,258
11/11/2022 Christopher A. Simon
President & CEO; Director
8,600   Gift at $0 per share. 0
11/01/2022 Roy Galvin
President, Global Plasma & BC
2,382   Award at $0 per share. 0
10/24/2022 Michelle L. Basil
EVP and General Counsel
180   Disposition at $80.39 per share. 14,470
10/24/2022 Stewart W. Strong
President, Global Hospital
75   Disposition at $80.39 per share. 6,029
09/19/2022 Michelle L. Basil
EVP and General Counsel
11,448   Disposition at $78.36 per share. 897,065
09/19/2022 Laurie A. Miller
SVP, Human Resources
212   Disposition at $76.25 per share. 16,165
09/19/2022 Michelle L. Basil
EVP and General Counsel
1,011   Derivative/Non-derivative trans. at $56.57 per share. 57,192
09/19/2022 Michelle L. Basil
EVP and General Counsel
4,213   Derivative/Non-derivative trans. at $41.64 per share. 175,429
09/19/2022 Michelle L. Basil
EVP and General Counsel
3,464   Derivative/Non-derivative trans. at $38.43 per share. 133,121
09/15/2022 Michelle L. Basil
EVP and General Counsel
6,029   Disposition at $78.5 per share. 473,276
09/15/2022 Michelle L. Basil
EVP and General Counsel
27,769   Disposition at $77.76 per share. 2,159,317
09/15/2022 Michelle L. Basil
EVP and General Counsel
3,173   Derivative/Non-derivative trans. at $56.57 per share. 179,496
09/15/2022 Michelle L. Basil
EVP and General Counsel
14,231   Derivative/Non-derivative trans. at $41.64 per share. 592,578
09/15/2022 Michelle L. Basil
EVP and General Counsel
11,154   Derivative/Non-derivative trans. at $38.43 per share. 428,648
09/06/2022 Josep Lluis Llorens
EVP, Global Manufacturing
101   Disposition at $73.78 per share. 7,451
08/15/2022 Mark W. Kroll
Director
8,016   Disposition at $73.71 per share. 590,859

Transaction Summary

Total insider purchases and sales reported to the SEC

Timeframe Transactions Shares
Last 3 months
0 Purchases
2 Sales
0
606
Last 6 months
1 Purchases
3 Sales
2,391
2,997
Last 12 months
16 Purchases
19 Sales
63,859
67,413

Officers and Executives

Mr. Christopher A. Simon
President, Chief Executive Officer & Director
Mr. James C. Darecca
Executive VP, Chief Financial & Accounting Officer
Ms. Anila Lingamneni
Chief Technology Officer & Executive VP
Mr. Stewart W. Strong
President-Global Hospital
Mr. David James Wilson
President-Plasma Business Unit
Mr. Josep Lluis Llorens
Executive VP-Global Manufacturing & Supply Chain
Ms. Olga Guyette
Director-Investor Relations
Ms. Laurie A. Miller
Chief Human Resources Officer & Senior VP
Ms. Ellen M. Zane
Independent Chairman
Mr. Michael J. Coyle
Independent Director
Mr. Lloyd E. Johnson
Independent Director
Mr. Charles J. Dockendorff
Independent Director
Dr. Mark W. Kroll
Independent Director
Ms. Catherine M. Burzik
Independent Director
Mr. Robert E. Abernathy
Independent Director
Dr. Claire Pomeroy
Independent Director
Link to MarketWatch's Slice.